Search

Search results

6 results found

Reproductive factors and expression of stem cell markers in benign breast tissue

Publication: Journal Article

Wang, Tengteng, Yujing J. Heng, BR Sardella, BA Rosner, RM Tamimi, and Lusine Yaghjyan. 2024. “Reproductive Factors and Expression of Stem Cell Markers in Benign Breast Tissue”. Am J Can Res 14: 5434-45.

Associations of circulating insulin growth factor-1 and insulin growth factor binding protein-3 with the expression of stem cell markers in benign breast tissue

Publication: Journal Article

Yaghjyan, Lusine, Yujing J. Heng, BR Sardella, D Murty, MB Mahoney, BA Rosner, and RM Tamimi. 2025. “Associations of Circulating Insulin Growth Factor-1 and Insulin Growth Factor Binding Protein-3 With the Expression of Stem Cell Markers in Benign Breast Tissue”. Breast Cancer Res 27 (1): 53.

HiRM Symposium 2024

News: April 09, 2024

Dr. Heng will be presenting a poster, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer" at the 2024 Harvard Institute of RNA Medicine Symposium.

Regular aspirin use, breast tumor characteristics and long-term breast cancer survival

Publication: Journal

Peng, C, T Wang, MD Holmes, WY Chen, KD Brantley, PA Le, YJ Heng, et al. 2025. “Regular Aspirin Use, Breast Tumor Characteristics and Long-Term Breast Cancer Survival”. Npj Breast Cancer.

Extracellular vesicle-encapsulated miR-30c-5p reduces aging-related liver fibrosis.

Publication: Journal Article

Rodrigues, Alice Cristina, Yujing J Heng, and Frank J Slack. 2024. “Extracellular Vesicle-Encapsulated MiR-30c-5p Reduces Aging-Related Liver Fibrosis.”. Aging Cell 23: e14310.

Associations of stem cell markers with lobular involution in benign breast tissue

Publication: Journal Article

Yaghjyan, Lusine, RM Tamimi, GM Baker, and YJ Heng. 2025. “Associations of Stem Cell Markers With Lobular Involution in Benign Breast Tissue”. Cancer Epidemiol Biomarkers Prev 34 (8): 1314-21.